Old Age, B Cell Function and Count Are the Critical Factors for Predicting Infection Risk in Patients With Autoimmune Rheumatic Diseases Undergoing Immunosuppression: A Cohort Study

被引:0
|
作者
Prakruthi, Jaladhar [1 ]
Kori, Devaraj [1 ]
Paramshetti, Shruti [1 ]
Ahamed, Sayid Fahad Nizar [1 ]
Panchagnula, Renuka [2 ]
Chandrashekara, S. [1 ]
机构
[1] Chanre Rheumatol & Immunol Ctr & Res, Bengaluru, Karnataka, India
[2] ChanRe Diagnost Lab, Bengaluru, Karnataka, India
关键词
ARD; IgG; immunosuppression; infection risk; neutrophil count; predictive parameters; TO-LYMPHOCYTE RATIO; TRANSPLANTATION; MANAGEMENT; NEUTROPHIL; SOCIETY; COMPLICATIONS; BIOMARKERS; MORTALITY;
D O I
10.1111/1756-185X.70187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The study aims to assess baseline immune parameters that predict infection risk in autoimmune rheumatic disease (ARD) patients, with the goal of identifying high-risk individuals requiring immunosuppressive therapy escalation, based on infection rates during a one-year follow-up. Methods: The independent cohort study was conducted at a tertiary rheumatology center in India from December 2019 to March 2022. It included adult participants with ARDs undergoing immunosuppression. Ethics approval and informed consent were obtained. Patients underwent detailed history, clinical examination, and baseline investigations, which included complete hemogram, inflammatory parameters, immunoglobulin levels, cellular levels of the immune system, complement levels, and viral markers. Descriptive statistics, ANOVA, chi-squared tests, t-tests, and Fisher's exact tests were used. OLS regression analyses identified significant predictors of infection risk. They were followed up for a period of 1 year for any infection episodes. Results: Of the 106 participants recruited, 4 were excluded due to disease-related complications during the 3-month period of follow-up. The mean age of the participants was 38.21 +/- 12.73 years, with an average follow-up duration of 13.1 +/- 8.35 months. Among the remaining 102 participants, younger age was associated with a lower infection risk (OR 1.047). Protective factors against infection included lower levels of immunoglobulin E (IgE) (OR 0.379), methotrexate (MTX) use (OR 0.247), and biologics (OR 0.543). Conversely, lower Immunoglobulin G (IgG), elevated neutrophil counts (OR 3.588), higher neutrophil-to-lymphocyte ratios (NLR) (OR 2.577), low platelet counts (OR 0.546), and steroid use, which increased the risk fivefold (OR 5.686), were identified as risk factors. Ordinary Least Squares (OLS) regression analysis highlighted age, IgG levels, CD19 lymphocyte counts, WBC counts, and ESR as significant predictors of infection risk between the groups. Conclusion: Older age, low IgG, low B cell count (CD19) predict susceptibility to infections; high neutrophil counts, low platelets, and elevated NLR are key predictors of developing infection in ARDs patients. Careful monitoring and tailored treatment strategies are essential to reduce infection risks. Further research is needed in this direction to develop predictive algorithms.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Risk Factors Associated with COVID-19 Breakthrough Infection Among Patients with Systemic Autoimmune Rheumatic Diseases: A Cohort Study
    Patel, Naomi
    Wang, Xiaosong
    Fu, Xiaoqing
    Kawano, Yumeko
    Cook, Claire
    Vanni, Kathleen
    Qian, Grace
    Banasiak, Emily
    Kowalski, Emily
    Zhang, Yuqing
    Sparks, Jeffrey
    Wallace, Zachary
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1419 - 1422
  • [2] THYMECTOMY IN PATIENTS WITH MYASTHENIA GRAVIS AND THE RISK OF AUTOIMMUNE RHEUMATIC DISEASES: A NATIONWIDE COHORT STUDY
    Chang, C. C.
    Chen, J. -H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1193 - 1193
  • [3] Thymectomy in patients with myasthenia gravis increases the risk of autoimmune rheumatic diseases: a nationwide cohort study
    Chang, Chi-Ching
    Lin, Tzu-Min
    Chang, Yu-Sheng
    Chen, Wei-Sheng
    Sheu, Jau-Jiuan
    Chen, Yi-Hsuan
    Chen, Jin-Hua
    RHEUMATOLOGY, 2019, 58 (01) : 135 - 143
  • [4] Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea
    Ryu, Hee Jung
    Han, Jin-Ok
    Lee, Sang Ah
    Seo, Mi Ryoung
    Choi, Hyo Jin
    Ko, Kwang-Pil
    Baek, Han Joo
    RHEUMATOLOGY, 2021, 60 (05) : 2427 - 2433
  • [5] Incidence and Risk Factors of Active Tuberculosis in Patients with Rheumatic Diseases Complicated with Tuberculosis Infection: A Multicenter Prospective Cohort Study
    Zhang, Lifan
    Liu, Yuchen
    Zou, Xiaoqing
    Chen, Shi
    Ma, Yanan
    Ma, Huimin
    Cao, Qifei
    Yang, Zhengrong
    Zhang, Fengchun
    Zhao, Yan
    Zeng, Xiaofeng
    Liu, Xiaoqing
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1600 - 1603
  • [6] Risk Factors and Outcomes for Repeat COVID-19 Infection Among Patients with Systemic Autoimmune Rheumatic Diseases: A Casecontrol Study
    Kowalski, Emily
    Wang, Xiaosong
    Patel, Naomi
    Kawano, Yumeko
    Cook, Claire
    Vanni, Kathleen
    Qian, Grace
    Bade, Katarina
    Srivatsan, Shruthi
    Williams, Zachary
    Wallace, Zachary
    Sparks, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 436 - 439
  • [7] RISK OF AUTOIMMUNE RHEUMATIC DISEASES IN PATIENTS WITH PALINDROMIC RHEUMATISM: A NATIONWIDE, POPULATION-BASED, COHORT STUDY
    Chen, H. -H.
    Chao, W. -C.
    Liao, T. -L.
    Lin, C. -H.
    Chen, D. -Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1744 - 1745
  • [8] Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study
    Chen, Hsin-Hua
    Chao, Wen-Cheng
    Liao, Tsai-Ling
    Lin, Ching-Heng
    Chen, Der-Yuan
    PLOS ONE, 2018, 13 (07):
  • [9] Comment on: Thymectomy in patients with myasthenia gravis increases the risk of autoimmune rheumatic diseases: a nationwide cohort study
    Ehrenfeld, Michael
    Shoenfeld, Yehuda
    RHEUMATOLOGY, 2020, 59 (02) : 451 - 452
  • [10] Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study
    Lin, Tzu-Min
    Chen, Wei-Sheng
    Sheu, Jau-Jiuan
    Chen, Yi-Hsuan
    Chen, Jin-Hua
    Chang, Chi-Ching
    PLOS ONE, 2018, 13 (01):